SCHEMBL6049334

SCHEMBL6049334

COc1ccc(N)cc1-c1cccc(CNC(C)C)c1.COc1ccc([N+](=O)[O-])cc1-c1cccc(CNC(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 1/20 0.46
CRHBP P24387 3/20 0.44
CRHR2 Q13324 3/20 0.44
HTT P42858 3/20 0.44
CYP2D6 P10635 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP2C9 P11712 2/20 0.44
RECQL P46063 2/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CASR P41180 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTR7 P34969 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3838650 0.94 MAPT (0.59) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL6049385 0.91 MAPT (0.54) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL3842196 0.88 CASR (0.52) CASRHTR7
SCHEMBL3842550 0.79 MAPT (0.52) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL3838152 0.78 MAPT (0.51) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL3864346 0.78 MAPT (0.48) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23901561 0.76 CYP2C19 (0.64) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL3838036 0.75 HTR7 (0.62) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL6049722 0.71 MEN1 (0.44) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL3842075 0.71 PDE4D (0.48) MAPTHTTGAAHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641465-A2 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID Theravance, Inc. (US) 2006-04-05 EP disclosed
WO-2005025555-A2 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID THERAVANCE, INC. (US) 2005-03-24 WO disclosed